Shield Therapeutics plc Tangible Net Worth Ratio
Shield Therapeutics plc tangible net worth ratio. Shield Therapeutics plc (STX) has a Tangible Net Worth Ratio of -3116.5% as of June 2024. This metric is calculated by deducting intangible assets (GBX13.77 Million) from net assets (GBX427.97K) and expressing it as a percentage of total net assets. A higher ratio means that more of the company's equity is backed by tangible, balance-sheet-verifiable assets rather than goodwill, patents, or brand value. Check how strategically is Shield Therapeutics plc's equity deployed to assess the company's strategic physical and investment asset allocation.
Tangible NW Ratio
Net Assets (Equity)
Intangible Assets
Total Assets
Tangible Net Worth Ratio of Shield Therapeutics plc (2016–2023)
Tangible net worth ratio of Shield Therapeutics plc from 2016 to 2023. This chart shows how Shield Therapeutics plc's Tangible Net Worth Ratio has changed across 8 annual periods from 2016 to 2023. As of June 2024, the ratio stands at -3116.5%, reflecting net assets of GBX427.97K with intangible assets of GBX13.77 Million GBX. See how liquid is Shield Therapeutics plc's working capital to evaluate short-term liquidity relative to the company's equity base.
Shield Therapeutics plc Tangible Net Worth Ratio by Year (2016–2023)
Shield Therapeutics plc tangible net worth ratio by year from 2016 to 2023. The table below presents the year-by-year Tangible Net Worth Ratio for Shield Therapeutics plc from 2016 to 2023, covering 8 annual filings. Each row shows net assets, intangible assets, total assets, the tangible net worth ratio, and the change in percentage points versus the prior year. For live market cap and overall valuation, see STX market cap.
| Year | Tangible NW Ratio | Net Assets (GBX) | Intangible Assets | Total Assets | Change (pp) |
|---|---|---|---|---|---|
| 2023 | 24.4% | GBX22.31 Million | GBX16.86 Million | GBX48.80 Million | ▲ +141.5 pp |
| 2022 | -117.1% | GBX5.43 Million | GBX11.78 Million | GBX22.07 Million | ▼ -151.7 pp |
| 2021 | 34.6% | GBX41.03 Million | GBX26.85 Million | GBX44.41 Million | ▲ +24.6 pp |
| 2020 | 9.9% | GBX30.28 Million | GBX27.27 Million | GBX32.53 Million | ▲ +3.0 pp |
| 2019 | 7.0% | GBX32.15 Million | GBX29.90 Million | GBX36.32 Million | ▼ -16.4 pp |
| 2018 | 23.4% | GBX40.43 Million | GBX30.96 Million | GBX43.38 Million | ▼ -3.9 pp |
| 2017 | 27.3% | GBX41.21 Million | GBX29.96 Million | GBX44.97 Million | ▼ -12.8 pp |
| 2016 | 40.1% | GBX48.40 Million | GBX28.98 Million | GBX52.38 Million | — |